| Literature DB >> 29458430 |
Fabian Muehlberg1, Kristin Arnhold2, Simone Fritschi2, Stephanie Funk2, Marcel Prothmann2, Josephine Kermer2, Leonora Zange2, Florian von Knobelsdorff-Brenkenhoff3, Jeanette Schulz-Menger2.
Abstract
BACKGROUND: Segmented phase-sensitive inversion recovery (PSIR) cardiovascular magnetic resonance (CMR) sequences are reference standard for non-invasive evaluation of myocardial fibrosis using late gadolinium enhancement (LGE). Several multi-slice LGE sequences have been introduced for faster acquisition in patients with arrhythmia and insufficient breathhold capability. The aim of this study was to assess the accuracy of several multi-slice LGE sequences to detect and quantify myocardial fibrosis in patients with ischemic and non-ischemic myocardial disease.Entities:
Keywords: CMR; Cardiac MR; Hypertrophic cardiomyopathy; Inflammatory heart disease; Late gadolinium enhancement; Myocardial infarction; Myocarditis; Single-shot
Mesh:
Substances:
Year: 2018 PMID: 29458430 PMCID: PMC5819178 DOI: 10.1186/s12968-018-0434-2
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
LGE sequence parameters
| FLASH-PSIR | SSFP-IR | SSFP-PSIR | ||
|---|---|---|---|---|
| Mode | Segmented | Multi-slice (single shot) | Multi-slice (single shot) | |
| TE | [ms] | 5.17 | 1.06 | 1.05 |
| Flip Angle | 30° | 50° | 65° | |
| Field of view | [mm] | 350–450 | 350–450 | 350–450 |
| Matrix | [mm] | 192 × 256 | 154 × 192 | 144 × 192 |
| Slice thickness | [mm] | 7 | 7 | 7 |
| Slice gap | [mm] | 0 | 0 | 0 |
TE Echo time
Patient Characteristics
| Chronic myocardial infarction | HCM | Inflammatory heart disease | |
|---|---|---|---|
| Number of patients | 203 | 50 | 45 |
| Gender [♂ / ♀] | 160 / 43 (78% / 22%) | 35 / 15 (72% / 28%) | 32 / 13 (71% / 29%) |
| Age [years] | 66.2 ± 10.7 | 62.0 ± 14.5 | 46.3 ± 15.4 * |
| BMI [kg/m2] | 27.6 ± 4.2 | 27.9 ± 4.3 | 25.8 ± 4.8 |
| HR [min-1] | 68.1 ± 11.5 | 69.8 ± 16.2 | 72.2 ± 12.9 |
| LVEF [%] | 52.9 ± 10.7 | 63.0 ± 10.9 * | 52.6 ± 13.3 |
| LVEDV-I [ml/m2] | 82.5 ± 24.3 | 69.6 ± 22.1 * | 90.9 ± 26.9 |
| SV-I [ml/m2] | 41.9 ± 8.7 | 43.3 ± 12.6 | 44.8 ± 8.9 |
| LVM-I [g/m2] | 59.3 ± 15.8 | 89.5 ± 28.4 * | 61.9 ± 17.2 |
| SR / Arrhythmia | 166 / 37 (82% / 18%) | 39 / 11 (78% / 22%) | 38 / 7 (84% / 16%) |
| LGE detected [yes / no] | 176 / 27 (87% / 13%) | 39 / 11 (78% / 22%) | 32 / 13 (71% / 29%) |
HCM Hypertrophic cardiomyopathy; BMI Body mass index; HR Heart rate; LVEF Left ventricular ejection fraction; LVEDV-I Left ventricular end-diastolic volume index; SV-I Stroke volume index; LVM-I Left ventricular mass index. SR Sinus rhythm. * p < 0.05
Fig. 1Representative LGE images. Three selected patients with chronic myocardial infarction (a-d), hypertrophic cardiomyopathy (e-h) and acute myocarditis (i-l) with typical LGE localization: subendocardial for infarction, patchy intramural for HCM and subepicardial for myocarditis. Horizontal rows display corresponding slices of LGE in the same patient, vertical columns show the used techniques: conventional segmented FLASH-PSIR (a;e;i), multi-slice bSSFP-IR (b;f;j), multi-slice bSSFP-PSIR with breathhold (c;g;k) and free-breathing multi-slice bSSFP-IR (d;h;l). nonbh = non-breathhold
Fig. 2Image quality scores. Values represent average image quality score for all patients in each group. Score system: 1 = excellent quality, no artifacts; 2 = good quality, minimal artifacts; 3 = moderate quality, some artifacts which may impair diagnostic quality; 4 = poor quality, unacceptable artifacts. * p < 0.05 within sequence. ** p < 0.05 towards FLASH-PSIR. ns = non-significant, p > 0.05. SR = sinus rhythm
Contrast-to-noise ratios
| All groups | Chronic infarction | HCM | Inflammatory heart disease | |
|---|---|---|---|---|
| FLASH-PSIR | 65.9 ± 71.9 | 67.9 ± 58.5 * | 80.4 ± 126.8 | 37.0 ± 21.3 * |
| SSFP-IR | 40.1 ± 26.8† | 43.2 ± 28.4 *† | 38.5 ± 19.9 † | 31.5 ± 22.2† |
| SSFP-PSIR | 137.8 ± 103.7† | 149.8 ± 114.9 *† | 118.4 ± 66.9† | 95.7 ± 49.2 *† |
| SSFP-PSIR nonbh | 125.9 ± 72.5† | 134.5 ± 72.5 *† | 101.7 ± 65.8† | 109.0 ± 73.4 † |
*p < 0.05 towards the other disease entities for the individual LGE sequence. † p < 0.05 towards FLASH-PSIR gold standard for individual disease entity
Fig. 3Visual assessment of LGE. a: Visual assessment of circumferential LGE extent. Columns represent number of segments with LGE for different circumferential extents across all study groups (chronic myocardial infarctions, HCM, inflammatory heart disease). b: Visual assessment of in-wall LGE location
Quantitative Assessment - LGE size
| All groups | Chronic infarction | HCM | Inflammatory heart disease | ||
|---|---|---|---|---|---|
| FLASH-PSIR | 8.96 ± 10.64 g | 7.47 ± 6.65 g | 15.42 ± 20.00 g | 9.39 ± 10.28 g | |
| SSFP-IR | 8.69 ± 10.75 g | 7.26 ± 7.03 g | 15.31 ± 20.02 g | 8.67 ± 9.66 g | p > 0.05 |
| SSFP-PSIR | 9.05 ± 10.84 g | 7.68 ± 7.18 g | 15.51 ± 20.31 g | 8.89 ± 9.30 g | p > 0.05 |
| SSFP-PSIR nonbh | 8.85 ± 10.71 g | 7.41 ± 6.91 g | 15.38 ± 19.96 g | 8.97 ± 9.94 g | p > 0.05 |
Values represent mean LGE size in gram. P values for each multi-slice sequence compared to FLASH-PSIR in all study groups
Fig. 4Bland-Altman plots of LGE mass. Blue dots represent mean LGE size (x-axis) versus delta LGE mass towards FLASH-PSIR (y-axis) in gram for each LGE sequence